Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Baxter
Harvard Business School
Express Scripts
Medtronic
McKinsey
McKesson

Last Updated: November 17, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Flupirtine

See Plans and Pricing

« Back to Dashboard

What is the drug development status for Flupirtine?

Flupirtine is an investigational drug.

There have been 4 clinical trials for Flupirtine. The most recent clinical trial was a Phase 1 trial, which was initiated on December 1st 2007.

The most common disease conditions in clinical trials are Neoplasm Metastasis, Sclerosis, and Multiple Sclerosis, Relapsing-Remitting. The leading clinical trial sponsors are Haining Health-Coming Biotech Co., Ltd., University Medicine Greifswald, and AWD.pharma GmbH & Co. KG.

Recent Clinical Trials for Flupirtine
TitleSponsorPhase
Clinical Studies by Using Accelerated PDX Model to Screen Drugs for Advanced Solid TumorHaining Health-Coming Biotech Co., Ltd.Phase 2
Effect of the Kv7-channel Opener Flupirtine on the Excitability of Human Peripheral Myelinated Axons in VivoLudwig-Maximilians - University of MunichPhase 1
Pharmacokinetics, Metabolism and Analgesic Effects of FlupirtineAWD.pharma GmbH & Co. KGPhase 1

See all Flupirtine clinical trials

Clinical Trial Summary for Flupirtine

Top disease conditions for Flupirtine
Top clinical trial sponsors for Flupirtine

See all Flupirtine clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Baxter
Dow
Mallinckrodt
Moodys
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.